AI assistant
Sending…
PFIZER INC — Director's Dealing 2008
Apr 16, 2008
29831_dirs_2008-04-15_b8636df3-e840-4cd9-b3dd-18090252b0f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ENCYSIVE PHARMACEUTICALS INC (ENCY)
CIK: 0000887023
Period of Report: 2008-04-11
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-04-11 | Common Stock | P | 155499 | $2.35 | Acquired | 67844054 | Indirect |
| 2008-04-14 | Common Stock | P | 1232412 | $2.35 | Acquired | 69076466 | Indirect |
Footnotes
F1: Shares are directly owned by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer Inc.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31